Published in J Pharm Sci on March 18, 2014
Recent advances in neonatal pharmacotherapy. Ann Pharmacother (2006) 1.38
Iontophoretic permselective property of human nail. J Dermatol Sci (2007) 0.97
Noninvasive transcutaneous sampling of glucose by electroporation. J Diabetes Sci Technol (2008) 0.95
Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci (2009) 0.91
Ungual and transungual drug delivery. Drug Dev Ind Pharm (2011) 0.89
Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia. J Control Release (2009) 0.86
Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique). Int J Pharm (2008) 0.85
Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci (2009) 0.85
Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J Pharm Sci (2011) 0.84
Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation. Int J Pharm (2009) 0.83
Transdermal drug delivery enhanced by low voltage electropulsation (LVE). Pharm Dev Technol (2009) 0.83
Constant voltage 'Iron'tophoresis. Pharm Dev Technol (2010) 0.82
"ChilDrive": a technique of combining regional cutaneous hypothermia with iontophoresis for the delivery of drugs to synovial fluid. Pharm Res (2009) 0.81
Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake. J Pharm Sci (2009) 0.81
Transungual delivery of terbinafine by iontophoresis in onychomycotic nails. Drug Dev Ind Pharm (2011) 0.80
Iontophoresis across the proximal nail fold to target drugs to the nail matrix. J Pharm Sci (2012) 0.80
Electroporation and transcutaneous sampling (ETS) of acyclovir. J Dermatol Sci (2007) 0.79
Microporation and 'iron'tophoresis for treating iron deficiency anemia. Pharm Res (2012) 0.79
Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration. J Drug Target (2012) 0.79
Delivery of cefotaxime to the brain via intranasal administration. Drug Dev Ind Pharm (2011) 0.77
Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci (2009) 0.77
Iontophoretic drug delivery for the treatment of scars. J Pharm Sci (2014) 0.77
Effect of polyethylene glycols on the trans-ungual delivery of terbinafine. Curr Drug Deliv (2010) 0.77
An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine. Pharm Res (2009) 0.77
Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis. J Pharm Sci (2010) 0.76
Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil. Pharmazie (2010) 0.76
Albumin microspheres for oral delivery of iron. J Drug Target (2010) 0.75
Brain-derived neurotrophic factor response in vulnerable and resilient genetic lines in the chick anxiety-depression model. Behav Brain Res (2013) 0.75
Minimally invasive transdermal delivery of iron-dextran. J Pharm Sci (2012) 0.75
Iontophoresis for treating nail diseases. Ther Deliv (2013) 0.75
Controlled-release injectable containing terbinafine/PLGA microspheres for onychomycosis treatment. J Pharm Sci (2014) 0.75
In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride. Pharm Dev Technol (2010) 0.75
Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt. J Pharm Sci (2012) 0.75
Trans-ungual delivery of itraconazole hydrochloride by iontophoresis. Drug Dev Ind Pharm (2014) 0.75